Spero Therapeutics Inc. (SPRO)
0.77
-0.09 (-10.48%)
At close: Mar 28, 2025, 3:58 PM
Spero Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Net Income | -68.57M | 22.81M | -46.41M | -89.76M | -78.28M | -60.92M | -41.66M | -39.89M | -32.64M | -13.15M |
| Depreciation & Amortization | 2K | 367K | 869K | 646K | 761K | 750K | 409K | 363K | 279K | 11K |
| Stock-Based Compensation | 7.79M | 7.93M | 9.12M | 9.43M | 4.89M | 3.78M | 2.75M | 1.43M | 180K | 21K |
| Other Working Capital | n/a | -71.14M | 22.57M | 12.95M | -10.42M | 6.27M | -1.16M | -1.91M | -148K | -501K |
| Other Non-Cash Items | 37.33M | 6.28M | 6.61M | 2.37M | 513K | 356K | -50K | -1.54M | 4.59M | 3.52M |
| Deferred Income Tax | n/a | n/a | n/a | 60K | -362K | -808K | n/a | 83K | -580K | -174K |
| Change in Working Capital | n/a | -70.38M | 22.09M | 12.9M | -13.39M | 6.83M | -1.07M | 443K | -792K | 170K |
| Operating Cash Flow | -23.44M | -32.99M | -7.73M | -64.35M | -85.87M | -50.02M | -39.63M | -39.11M | -28.96M | -9.61M |
| Capital Expenditures | n/a | n/a | n/a | 39K | -157K | -314K | -2.44M | -27K | -830K | -232K |
| Acquisitions | n/a | n/a | n/a | -39K | -10.63M | -29.84M | 83.16M | -1.18M | n/a | n/a |
| Purchase of Investments | n/a | n/a | -26.97M | -43.91M | -45.72M | -88.99M | -130.18M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | 60.78M | 51.55M | 56.35M | 118.84M | 49.45M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | 33.81M | 39K | 10.63M | 29.84M | -83.16M | -27K | n/a | n/a |
| Investing Cash Flow | n/a | n/a | 33.81M | 7.67M | 10.47M | 29.53M | -83.16M | -27K | -830K | -232K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | -54.06M | 48.68M | 52.22M | 350K | -977K | 38.36M | 34.41M | 15.28M |
| Financial Cash Flow | n/a | 221K | -29.55M | 84.05M | 130.88M | 16.14M | 69.52M | 116.11M | 34.41M | 15.28M |
| Net Cash Flow | -23.44M | -32.77M | -3.48M | 27.38M | 55.48M | -4.35M | -53.26M | 76.97M | 4.62M | 5.43M |
| Free Cash Flow | -23.44M | -32.99M | -7.73M | -64.31M | -86.03M | -50.33M | -42.06M | -39.14M | -29.79M | -9.84M |